2-(2-((4-Fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetic acid, 97.0%, 5g

Appareil à ultrasons série D, 5,4 l, D 60 1 pièce

2-Chloro-6-methoxy-4-methylpyridine, 95.0%, 250mg

Di-tert-butyl diisopropylphosphoramidite, 95.0%, 1g

(R)-1-(5-Chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea hydrochloride, 98%, 100mg

3-(Aminomethyl)-N-benzyloxetan-3-amine, 95.0%, 500mg

N-Boc-4-Acetylpiperidine, 98.0%, 100g

(4S,4'S)-2,2'-(Propane-2,2-diyl)bis(4-methyl-4,5-dihydrooxazole), 97%, 1g

2,5,6,7-tetrahydro-3H-cyclopenta[c]pyridazin-3-one, 95.0%, 250mg

2,6,7-Trihydroxy-9-(2-hydroxyphenyl)-3H-xanthen-3-one, 98%, 250mg

5-(2-Aminoethyl)-4-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one hydrochloride, 95.0%, 1g

1-(1,2,3,4-TETRAHYDROQUINOLIN-6-YL)ETHANONE, 95.0%, 100mg

Nonanamide, 250mg